NIT
SLDB icon

NumerixS Investment Technologies’s Solid Biosciences SLDB Stock Holding History

NumerixS Investment Technologies’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,280
Closed -$184K – 1322
2019
Q1 		$184K Buy
+1,280
New +$321K 0.02% 691

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

NumerixS Investment Technologies's SLDB Position: Q2 2019 in Review

NumerixS Investment Technologies sold out of Solid Biosciences (SLDB) in Q2 2019, closing a stake of 1,280 shares — an estimated $184K sold.

NumerixS Investment Technologies first reported a position in SLDB in Q1 2019 and held it in 1 quarter. The position peaked at $184K in Q1 2019. 74 funds tracked by Wall St. Rank hold SLDB as of Q2 2019.

  • NumerixS Investment Technologies reported no remaining Solid Biosciences position as of Q2 2019 after selling out during the quarter.
  • NumerixS Investment Technologies sold 1,280 Solid Biosciences shares in Q2 2019, an estimated $184K.
  • NumerixS Investment Technologies first reported a position in Solid Biosciences in Q1 2019 and held it in 1 quarter.
  • NumerixS Investment Technologies's Solid Biosciences position peaked at $184K in Q1 2019.
  • 74 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2019.

Based on NumerixS Investment Technologies's 13F filing for Q2 2019, filed 13 Aug 2019.